Lake Street Capital Markets initiated coverage on Sensus Healthcare (NASDAQ:SRTS), a medical device company specializing in non-invasive treatments for non-melanoma skin cancer (NMSC) and other skin ...

Lake Street initiated coverage of Sensus Healthcare (SRTS) with a Buy rating and $18 price target Sensus’ superficial radiation therapy is a ...

Sensus Healthcare, Inc.’s SRTS share price has surged by 19.87%, which has investors questioning if this is right time to ...

Most health insurance providers and Medicare cover Gentle Cure. Medicare Part A covers radiation therapy when you are receiving inpatient treatment in the hospital. Part B covers radiation therapy for ...

We recently compiled a list of the 10 Under-the-Radar Stocks with Massive Upside for 2025. In this article, we are going to take a look at where Sensus Healthcare, Inc. (NASDAQ:SRTS) stands against ...

Jan. 16, 2025 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most ...

BURR RIDGE, Ill., Jan. 16, 2025 /PRNewswire/ -- SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT) ...

About SkinCure Oncology SkinCure Oncology is the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT), the most ...

First-half revenue up from £5.5mn to £25.5mn Pre-tax profit of £2.5mn, up from a loss of £4.6mn Four new contracts signed worth £182mn £334mn active order book £1.2bn pipeline of contract ...

The UAB Department of Radiation Oncology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive ...